文献速递妇科生殖医学

子宫内膜异位症相关腹膜粘连形成:分子机制与临床意义

Endometriosis-related peritoneal adhesion formation: molecular mechanisms and clinical significance.
PubMed 文献 · Hum Reprod Update · 2026-08-14

本文为叙述性综述,检索2000年1月至2026年2月PubMed、Embase和Cochrane Library,纳入124项研究,探讨子宫内膜异位症中腹膜粘连形成的生理修复、分子机制及治疗策略。综述指出子宫内膜异位症通过慢性炎症、免疫改变、反复组织损伤和经血碎片及铁暴露等改变腹膜微环境,可能促进粘连形成,但人类直接证据有限,目前尚无有效药物预防或治疗粘连。

要点

  • 子宫内膜异位症影响10-11%育龄女性,与粘连强相关。
  • 粘连形成涉及炎症、凝血-纤溶失衡和纤维增生性重塑。
  • 目前预防聚焦手术中干预,尚无有效药物预防粘连。

核心结论

  • 子宫内膜异位症中粘连生物学主要反映保守的伤口愈合通路,但发生在慢性改变的腹膜微环境中,降低粘连形成阈值并促进持续和复发。

研究设计与样本

  • 叙述性综述,检索PubMed、Embase和Cochrane Library 2000年1月至2026年2月文献,纳入随机对照试验、观察性研究、系统综述和相关实验研究,排除病例报告和非英文出版物,共纳入124项研究。

主要发现

  • 粘连形成源于腹膜修复失调,涉及炎症、凝血-纤溶失衡和纤维增生性重塑。
  • 子宫内膜异位症创造慢性炎症、免疫反应改变、反复组织损伤及经血碎片和铁暴露的腹膜环境,可能促进粘连形成。
  • 许多机制理解来自实验模型,来自患者的直接证据仍有限。

关键数值与推荐

  • 子宫内膜异位症影响10-11%育龄女性。
  • 共纳入124项研究。

临床怎么用

  • 目前预防子宫内膜异位症粘连形成主要聚焦术中干预,以限制子宫内膜异位症相关手术后粘连发展,而非在无手术情况下预防疾病相关粘连形成。
  • 实验研究讨论的潜在药物疗法包括激素治疗,可能干扰子宫内膜异位症相关粘连形成。
  • 目前尚无有效药物疗法预防或治疗粘连,是子宫内膜异位症护理中未满足的临床需求。

局限性

  • 许多机制理解来自实验模型,来自患者的直接证据仍有限。
  • 目前尚无有效药物疗法预防或治疗粘连。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peritoneal adhesions are a major and often under-recognized cause of morbidity following abdominopelvic inflammation and surgery, contributing to chronic pelvic pain, infertility, bowel obstruction, and surgical complications. Endometriosis, affecting 10-11% of reproductive-age women, is strongly associated with adhesions; however, whether adhesion formation in endometriosis reflects general peritoneal injury or disease-specific mechanisms remains unclear. OBJECTIVE AND RATIONALE: This narrative review examines (i) physiological peritoneal healing and mechanisms of adhesion formation, (ii) how the altered peritoneal microenvironment in endometriosis may modify adhesiogenesis, and (iii) current and theoretical therapeutic and preventative strategies for adhesions in endometriosis. This will improve current understanding of adhesiogenesis and the implications of adhesions in women with endometriosis, and will identify areas for future research to reduce morbidity in this patient population. SEARCH METHODS: Literature searches were performed in PubMed, Embase and Cochrane Library using combinations of the terms 'endometriosis', 'adhesions', 'pelvic', 'abdominal', 'peritoneal' between January 2000 and February 2026. Randomized-controlled trials, observational studies, systematic reviews, and relevant experimental studies were included. Case reports and non-English publications were excluded. A total of 124 studies were included in this literature review. OUTCOMES: Adhesion formation results from dysregulated peritoneal repair involving inflammation, coagulation-fibrinolysis imbalance, and fibroproliferative remodelling. Evidence suggests that endometriosis creates a peritoneal environment characterized by chronic inflammation, altered immune responses, repeated tissue injury, and exposure to menstrual debris and iron, which may promote adhesiogenesis. However, much mechanistic understanding is derived from experimental models, and direct evidence from patients remains limited. Prevention of adhesiogenesis in endometriosis currently focuses on intra-operative interventions to limit adhesion development following endometriosis-related surgery, rather than preventing disease-related adhesiogenesis in the absence of surgery. We discuss potential pharmacotherapies, including hormonal treatments, identified by experimental studies, which may perturb endometriosis-related adhesiogenesis. WIDER IMPLICATIONS: Current data support a model in which adhesion biology in endometriosis largely reflects conserved wound-healing pathways but develop within a chronically altered peritoneal microenvironment that lowers the threshold for adhesiogenesis and promotes persistence and recurrence. Clarifying endometriosis-specific drivers and generating robust human data are essential to develop targeted adhesion-prevention strategies and improve long-term outcomes for affected patients. Notably, there are currently no effective pharmacological therapies to prevent or treat adhesions, representing a major unmet clinical need in endometriosis care. REGISTRATION NUMBER: N/A.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Macpherson B, Zindel J, Mueller M, et al. Endometriosis-related peritoneal adhesion formation: molecular mechanisms and clinical significance. Hum Reprod Update. 2026. PMID: 42600047. doi:10.1093/humupd/dmag021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。